Literature DB >> 1689245

A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study.

H Vyas1, D J Matthew, P J Milla.   

Abstract

A comparative study of the efficacy of pH sensitive enteric coated microspheres (ECM) with an enteric coated tablet (ECT) pancreatic enzyme preparation was carried out in 20 children with cystic fibrosis in a double-blind double-placebo crossover manner. Steatorrhoea was assessed by 3 day faecal fat analysis and dosage of medication, stool frequency and consistency; abdominal pain and appetite were documented by a patient-kept diary card. ECM controlled steatorrhoea (11.8 +/- 9.2 g vs 23.2 +/- 18.9 g, P less than 0.02), stool frequency (1.7 +/- 0.6 vs 2.1 +/- 0.9, P less than 0.01) and abdominal pain (8.8 +/- 13.8 vs 23.4 +/- 24.1, P less than 0.05) significantly better than ECT. Out of 20 patients 17 preferred ECM to ECT (P less than 0.00036). ECM preparations should allow more satisfactory dietary management of patients with cystic fibrosis with longterm beneficial effect.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689245     DOI: 10.1007/bf02106281

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts.

Authors:  D Y Graham
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

2.  Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.

Authors:  E P DiMagno; J R Malagelada; V L Go; C G Moertel
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

3.  Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency.

Authors:  P T Regan; J R Malagelada; E P DiMagno; S L Glanzman; V L Go
Journal:  N Engl J Med       Date:  1977-10-20       Impact factor: 91.245

4.  Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.

Authors:  R Gow; R Bradbear; P Francis; R Shepherd
Journal:  Lancet       Date:  1981-11-14       Impact factor: 79.321

5.  Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption.

Authors:  K Gaskin; D Gurwitz; P Durie; M Corey; H Levison; G Forstner
Journal:  J Pediatr       Date:  1982-06       Impact factor: 4.406

6.  Comparison of four pancreatic extracts in cystic fibrosis.

Authors:  D W Beverley; J Kelleher; A MacDonald; J M Littlewood; T Robinson; M P Walters
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

7.  The effect of cimetidine on meal-stimulated gastric function and exogenous pancreatic enzymes in cystic fibrosis.

Authors:  D J Cameron; R Pitcher-Wilmott; P J Milla; J More; G K Ghale; D J Matthew; J T Harries
Journal:  Hum Nutr Clin Nutr       Date:  1982

8.  Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis.

Authors:  E H Mischler; S Parrell; P M Farrell; G B Odell
Journal:  Am J Dis Child       Date:  1982-12

9.  Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.

Authors:  P R Durie; L Bell; W Linton; M L Corey; G G Forstner
Journal:  Gut       Date:  1980-09       Impact factor: 23.059

10.  Comparative trial of pancrex V forte and nutrizym in treatment of malabsorption in cystic fibrosis.

Authors:  M C Goodchild; E Sagaró; G A Brown; P M Cruchley; H R Jukes; C M Anderson
Journal:  Br Med J       Date:  1974-09-21
View more
  6 in total

1.  Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.

Authors:  Gavin R Graff; John McNamara; James Royall; Steven Caras; Kristin Forssmann
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 2.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 3.  Nutritional management of cystic fibrosis.

Authors:  A MacDonald
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

4.  A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis.

Authors:  I M Bowler; S P Wolfe; H M Owens; T A Sheldon; J M Littlewood; M P Walters
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

5.  Pancreatic enzyme replacement therapy for people with cystic fibrosis.

Authors:  Usha Rani R Somaraju; Arturo Solis-Moya
Journal:  Cochrane Database Syst Rev       Date:  2020-08-05

6.  Efficacy and safety of pancreatic enzyme replacement therapy on exocrine pancreatic insufficiency: a meta-analysis.

Authors:  Can Gan; Yan-Hua Chen; Ling Liu; Jin-Hang Gao; Huan Tong; Cheng-Wei Tang; Rui Liu
Journal:  Oncotarget       Date:  2017-10-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.